{"id":"https://openalex.org/W1995227746","doi":"https://doi.org/10.1021/jm960861b","title":"Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine: A Centrally Active Corticotropin-Releasing Factor1 Receptor Antagonist","display_name":"Synthesis and Oral Efficacy of a 4-(Butylethylamino)pyrrolo[2,3-d]pyrimidine: A Centrally Active Corticotropin-Releasing Factor1 Receptor Antagonist","alternate_titles":[],"publication_year":1997,"publication_date":"1997-05-01","ids":{"openalex":"https://openalex.org/W1995227746","doi":"https://doi.org/10.1021/jm960861b","mag":"1995227746","pmid":"https://pubmed.ncbi.nlm.nih.gov/9171885"},"language":"en","primary_location":{"id":"doi:10.1021/jm960861b","doi":"https://doi.org/10.1021/jm960861b","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm960861b","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995227746"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009999364","display_name":"Yuhpyng L. Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yuhpyng L. Chen","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022528712","display_name":"Robert S. Mansbach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert S. Mansbach","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068800873","display_name":"Steven M. Winter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven M. Winter","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109981934","display_name":"Elizabeth Brooks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elizabeth Brooks","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Judith Collins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Judith Collins","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008402669","display_name":"Michael L. Corman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael L. Corman","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078851167","display_name":"Audrey R. Dunaiskis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Audrey R. Dunaiskis","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006005155","display_name":"W. Stephen Faraci","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Stephen Faraci","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087616984","display_name":"Randall J. Gallaschun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Randall J. Gallaschun","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037158935","display_name":"Anne W. Schmidt","orcid":"https://orcid.org/0000-0003-3222-5661","observed_orcids":["https://orcid.org/0000-0003-3222-5661"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Schmidt","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113586761","display_name":"David W. Schulz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David W. Schulz","raw_affiliation_strings":["Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry and Neuroscience Departments, Central Research Division, Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5009999364"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":3.6106,"has_fulltext":false,"cited_by_count":118,"citation_normalized_percentile":{"value":0.94204927,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"40","issue":"11","first_page":"1749","last_page":"1754"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.7592999935150146,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.08699999749660492,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.024800000712275505,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crf1-receptor-antagonist","display_name":"CRF1 receptor antagonist","score":0.8640000224113464},{"id":"https://openalex.org/keywords/corticotropin-releasing-factor","display_name":"corticotropin-releasing factor","score":0.9139999747276306},{"id":"https://openalex.org/keywords/pyrrolo-2-3-d-pyrimidine","display_name":"pyrrolo[2,3-d]pyrimidine","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cp-154-526","display_name":"CP-154,526","score":0.9520000219345093},{"id":"https://openalex.org/keywords/nonpeptide-antagonists","display_name":"non-peptide antagonists","score":0.6700000166893005},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.6710000038146973},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9869999885559082},{"id":"https://openalex.org/keywords/anxiolytic-like-effects","display_name":"anxiolytic-like effects","score":0.7929999828338623},{"id":"https://openalex.org/keywords/oral-efficacy","display_name":"oral efficacy","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9089977741241455},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7730358839035034},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.7197996377944946},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.6514713764190674},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.554527223110199},{"id":"https://openalex.org/C3017990168","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Orally active","level":3,"score":0.5109699964523315},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4954441785812378},{"id":"https://openalex.org/C131779359","wikidata":"https://www.wikidata.org/wiki/Q471875","display_name":"Amine gas treating","level":2,"score":0.4808950424194336},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.4799242615699768},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4642309546470642},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44854775071144104},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4264858067035675},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.42455852031707764},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19728341698646545},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07036131620407104},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005239","descriptor_name":"Fear","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013216","descriptor_name":"Reflex, Startle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018019","descriptor_name":"Receptors, Corticotropin-Releasing Hormone","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018019","descriptor_name":"Receptors, Corticotropin-Releasing Hormone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm960861b","doi":"https://doi.org/10.1021/jm960861b","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm960861b","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:9171885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9171885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1974253960","https://openalex.org/W1983768860","https://openalex.org/W1991192480","https://openalex.org/W1997003528","https://openalex.org/W1999626047","https://openalex.org/W2017168736","https://openalex.org/W2032725109","https://openalex.org/W2033013734","https://openalex.org/W2034863408","https://openalex.org/W2051119043","https://openalex.org/W2059692874","https://openalex.org/W2079718339","https://openalex.org/W2081264545","https://openalex.org/W2095036452","https://openalex.org/W2171846995","https://openalex.org/W2402656846"],"related_works":["https://openalex.org/W2084656235","https://openalex.org/W2049181290","https://openalex.org/W1988622144","https://openalex.org/W1990389604","https://openalex.org/W2046934118","https://openalex.org/W2330015061","https://openalex.org/W1966434039","https://openalex.org/W2009585554","https://openalex.org/W2121217769","https://openalex.org/W1980345475"],"abstract_inverted_index":{"The":[0,22],"syntheses":[1],"of":[2,36,44],"a":[3],"centrally":[4],"active":[5],"nonpeptide":[6],"CRF1":[7,25],"receptor":[8,26],"antagonist":[9],"2,":[10,32],"butylethyl[2,5-dimethyl-7-(2,4,6-trimethylphenyl)-7H-pyrrolo":[11],"[2,3-d]pyrimidin-4-yl]amine":[12],"(CP-154,526),":[13],"and":[14,18,40],"its":[15],"analogs":[16],"11-14":[17],"[3H]-2":[19],"are":[20,48],"reported.":[21],"in":[23,29,38],"vitro":[24],"binding":[27],"affinity":[28],"the":[30,33,41],"series":[31],"pharmacokinetic":[34],"properties":[35],"2":[37,47],"rats,":[39],"anxiolytic-like":[42],"effects":[43],"orally":[45],"administered":[46],"presented.":[49]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995227746","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
